Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure

Abstract

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.The research reported in this monograph was commissioned by the HTA Programme on behalf of the National Institute for Clinical Excellence (NICE). Technology assessment reports are completed in a limited time to inform the appraisal and guidance development processes managed by NICE. The review brings together evidence on key aspects of the use of the technology concerned. However, appraisals and guidance produced by NICE are informed by a wide range of sources.The research reported in this monograph was funded as project number 01/46/01.The views expressed in this publication are those of the authors and not necessarily those of the HTA Programme, NICE or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for any recommendations made by the authors. Criteria for inclusion in the HTA monograph seriesRe...

A Cost Evaluation of Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil

“…In the PD group, infection predominated as the main cause of clinical complications and death (Figure 1). Infection is known to be a relevant issue in developing countries (32)(33)(34)(35). Nevertheless, the causes and their impacts on costs for infections must be further investigated.…”

The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation

“…100 This analysis used the hospital haemodialysis costs excluding training and access costs, and the cost of interdialytic complications (to avoid possible double-counting of fracture-related and cardiovascular eventrelated hospitalisations). The majority (64%) of haemodialysis patients receive haemodialysis in hospital, with most of the remainder receiving treatment in satellite dialysis units rather than at home.…”

Estimating patient-borne water and electricity costs in home hemodialysis: a simulation

“…6,[8][9][10][11][12][13][14] The annual utility cost of home hemodialysis in Edmonton in this study ranges from $420 to $1269. Not surprisingly, the most expensive form of dialysis is a prescription used for 8-hour 6-times-weekly nocturnal hemodialysis and the least expensive is for a prescription of conventional 4-hour thrice-weekly hemodialysis.…”

“…Although there is considerable variability in analytic approaches and their results, it is generally accepted that home hemodialysis is associated with fewer human resources and lower facility management expenses. [6][7][8][9][10][11][12][13][14] However, when patients self-dialyze at home, some expenses (such as the utility costs of running the dialysis equipment) are transferred to the patient. The aim of this study was to measure utility consumption (water and electricity) required to perform various prescriptions of home hemodialysis, and estimate the associated costs.…”